PepGen Inc.
NASDAQ:PEPGBiotechnology
Healthcare
$3.83 +5.29%
+$0.09 today
- Market cap
- $265.27M
- Beta
- 1.93
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$1.12
52W Low $1.01High $7.80
Volume 3.39M
Average 1.37M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$81.64M
FY 2025 · Annual
Investing Cash Flow
-$15.23M
FY 2025 · Annual
Financing Cash Flow
$107.98M
FY 2025 · Annual
+21.7% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.28M) | (69.1M) | (78.63M) | (89.98M) | (89.66M) |
| Depreciation & Amortization | 178K | 493K | 850K | 5.25M | 5.15M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.53M | 4.76M | 7.05M | 11.46M | 10.61M |
| Change in Working Capital | 2.77M | 4.51M | 1.95M | (5.25M) | (6.22M) |
| Accounts Receivables | (4.34M) | 4.18M | 26K | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.51M | (1.41M) | (369K) | 722K | (935K) |
| Other Working Capital | 4.61M | 1.73M | 2.29M | (5.97M) | (5.29M) |
| Other Non-Cash Items | 196K | 76K | (220K) | (3.86M) | (1.51M) |
| Operating Cash Flow | (22.6M) | (59.27M) | (69M) | (82.37M) | (81.64M) |
| Capital Expenditures | (500K) | (3.76M) | (2.6M) | (497K) | (264K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (29.4M) | (145.17M) | (93.97M) |
| Sales of Investments | 0 | 0 | 0 | 108M | 79M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (500K) | (3.76M) | (32M) | (37.67M) | (15.24M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 114.27M | 0 | 86.78M | 108.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.39M) | (2.07M) | (189K) | 1.97M | 0 |
| Financing Cash Flow | 147.66M | 112.19M | (189K) | 88.75M | 107.98M |
| Effect of Forex Changes | 33K | (316K) | 286K | (62K) | (16K) |
| Net Change in Cash | 124.59M | 48.86M | (100.9M) | (31.35M) | 11.09M |
| Free Cash Flow | (23.1M) | (63.02M) | (71.6M) | (82.87M) | (81.9M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$89.7M
+ D&A$5.1M
+ Stock-Based Comp$10.6M
+ Deferred Tax$0
- Working Capital-$6.2M
- Other Non-Cash-$1.5M
= Operating Cash Flow-$81.6M
- Capex-$264.0K
= Free Cash Flow-$81.9M
Analysis
FY2025 free cash flow is -$81.9M. FCF conversion is 91.3% of net income. Operating cash flow was -$81.6M, with capex of -$264.0K. The largest bridge item is Stock-Based Comp at $10.6M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 424B5 | 424B5 filing | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| 424B5 | 424B5 filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 |
Does PEPG generate free cash flow?
PepGen Inc. (PEPG) generated -$81.90M of free cash flow in fiscal 2025.
How much operating cash flow does PEPG produce?
Operating cash flow was -$81.64M, before capital expenditures of $264,000.00.
Continue the stock analysis
Jump to another research area for this company.